-
CD36-Driven Lipid Signaling Promotes AML Immune Escape
2026-09-16
Guo et al. identify a non-canonical CD36-dependent lipid program in acute myeloid leukemia that combines oxidized LDL sensing with palmitate transfer to activate TLR4–LYN–MYD88–NF-κB signaling and suppress T-cell activity. The study further shows that lipid excess and decitabine can strengthen this immunosuppressive state, whereas statin-mediated pathway restriction improves decitabine efficacy in preclinical models.
-
Inducing Right Ventricular-like Cardiomyocytes from hPSCs
2026-09-16
Saito et al. developed a differentiation strategy that biases human pluripotent stem cells toward anterior second heart field-like progenitors and right ventricular-like cardiomyocytes. By modulating endogenous BMP signaling during mesoderm formation, the study generated cells with distinct chamber-associated gene expression and functional phenotypes, supporting more precise models of right-sided cardiac disease.
-
Naloxone (hydrochloride): Assay Guide
2026-09-15
A scenario-based guide to using Naloxone (hydrochloride), SKU B8208, in opioid receptor, neural stem cell, immune, and cell viability workflows. It focuses on formulation control, assay interpretation, vendor reliability, and practical safeguards against mechanism or solvent-related confounding.
-
rhBNP, Selenium Recycling, and Renal Ferroptosis
2026-09-15
This study identifies Selenocysteine Lyase (SCLY)-dependent selenium recycling as a mechanistic link between recombinant human brain natriuretic peptide (rhBNP) and protection from renal ischemia-reperfusion injury. Its combination of clinical association data, rat modeling, transcriptomics, and HK2-cell gain- and loss-of-function experiments supports ferroptosis suppression as a potential therapeutic direction while leaving important translational questions unresolved.
-
Thioredoxin Control of CHK1 Inhibitor Sensitivity
2026-09-14
The reference study identifies the thioredoxin system as a determinant of CHK1 inhibitor sensitivity in non-small cell lung cancer research. Its mechanistic contribution is the connection between Trx1-dependent redox recycling of RRM1, deoxynucleotide availability, and the response to CHK1 inhibition, supporting a rational combination strategy with thioredoxin reductase inhibition.
-
Lung-Targeted Risedronate/Vitamin D3 Delivery
2026-09-14
The reference study developed PAMAM-G5 dendrimers for combined pulmonary delivery of Risedronate Sodium and vitamin D3, aiming to improve systemic exposure while reducing gastrointestinal limitations. In an osteoporosis rat model, the formulation improved calcium, phosphorus, bone mineral density, WNT-related signaling, and metabolomic profiles, supporting lung-targeted delivery as a promising experimental strategy.
-
Gamithromycin Workflows for Respiratory Research
2026-09-13
Build more predictive respiratory infection assays by pairing Gamithromycin susceptibility testing with lung-compartment pharmacokinetics and intracellular exposure measurements. This workflow helps distinguish true antimicrobial activity from matrix effects, resistance, precipitation, and misleading plasma-only readouts.
-
nor-NOHA: Arginine Metabolism as a Translational Lever
2026-09-12
nor-NOHA acetate offers a reversible way to interrogate arginase–NOS competition, cancer-cell behavior, and endothelial biology. This thought-leadership analysis connects established HepG2 and vascular findings with the CD36-driven immune escape program reported in AML, while distinguishing validated evidence from forward-looking hypotheses.
-
TaqI Restriction Endonuclease: Practical Guide
2026-09-11
TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA at the TCGA recognition site. It is intended for research workflows such as cloning and DNA analysis, not for diagnostic or medical use.
-
Adefovir Pharmacokinetics and OAT1 Phenotyping
2026-09-11
The 2024 reference study uses population pharmacokinetic modeling to explain why adefovir exposure rose modestly in a transporter cocktail without evidence of altered renal OAT1 elimination. Its analysis separates apparent absorption or prodrug conversion effects from renal disposition and supports renal clearance as a practical OAT1 phenotype metric at the studied doses.
-
ONX-0914 (PR-957) Workflow for Immune Assays
2026-09-10
ONX-0914 (PR-957) provides a selective way to interrogate LMP7-dependent cytokine signaling without intentionally targeting the constitutive β5 proteasome subunit. This workflow connects concentration-response design, PBMC cytokine profiling, autoimmune-model interpretation, and troubleshooting while using a neuroscience study as a guide for stronger causal assay architecture.
-
NAT1–ENO1–Lactate Axis in Colorectal Cancer
2026-09-10
A 2026 MedComm study identifies a metabolic–immune circuit in colorectal cancer in which NAT1 restrains ENO1-driven glycolysis and lactate production, while NAT1 loss promotes TRAF6-dependent stabilization of PD-L1. The findings connect tumor lactate metabolism with immune-checkpoint regulation and provide a mechanistic framework for studying responses to PD-1 or PD-L1 blockade.
-
Acetylcholine Chloride and Gut-Brain Translation
2026-09-09
The gut-brain cholinergic axis is emerging as a mechanistic bridge between microbiota biology and seizure control. This thought-leadership article explains how Acetylcholine Chloride can support causal pharmacology, circuit-level validation, and translational decision-making without being mistaken for a substitute for microbial or vagal mechanisms.
-
JHU-083: Glutaminase Pathway Research Workflows
2026-09-09
JHU-083 is a selective glutaminase research tool for studying cerebral CD11b cells, glutamate regulation, and experimental cerebral malaria. This workflow-focused guide connects its neurological applications with a recent oxidative-stress study while clearly separating established evidence from transferable assay design.
-
ECL Chemiluminescent Substrate Detection
2026-09-08
The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) uses horseradish peroxidase (HRP) chemiluminescence for sensitive immunoblot detection on nitrocellulose and PVDF membranes. Product information describes low-picogram sensitivity, a 6–8 hour optimized signal window, and working-reagent stability for 24 hours.